Approach to the patient with unexplained chest pain

American Journal of Gastroenterology

Volumn 95, Issue 8 SUPPL., 2000, Pages

  Katz, Philip O ^a   Castell, Donald O ^a  

^a GRADUATE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; DILTIAZEM; GLYCERYL TRINITRATE; HISTAMINE H2 RECEPTOR ANTAGONIST; IMIPRAMINE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; RABEPRAZOLE; TRAZODONE;

ARTICLE; BARIUM MEAL; CLINICAL FEATURE; CORONARY ARTERY OBSTRUCTION; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; ESOPHAGUS MOTILITY; GASTROESOPHAGEAL REFLUX; HUMAN; MANOMETRY; PH MEASUREMENT; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; THORAX PAIN;

EID: 0033887929     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9270(00)01072-8     Document Type: Article

References (28)

1. Prospective study on prevalence of esophageal chest pain in patients referred on an elective basis to a cardiac unit for suspected myocardial ischemia
2. Exertional gastroesophageal reflux: A mechanism for symptoms in patients with angina pectoris and normal coronary angiograms
3. The contribution of gastroesophageal reflux to chest pain in patients with coronary artery disease
4. Prospective evaluation of esophageal motility with provocative testing in patients with chest pain and mitral valve prolapse
5. Seven year survival of patients with normal or near normal coronary arteriograms: A CASS registry study
6. Unexplained chest pain in patients with normal coronary arteriograms: A follow-up study of functional status
7. Esophageal chest pain: Current controversies, pathogenesis, diagnosis, and therapy
8. Esophageal tests in the evaluation of non-cardiac chest pain
9. Oesophageal sensitivity to acid in patients with non-cardiac chest pain: Is the oesophagus hypersensitive?
10. Twenty-four hour esophageal pH monitoring: The most useful test for evaluation non-cardiac chest pain
11. Esophageal testing in patients with non-cardiac chest pain and/or dysphagia
12. Abnormal sensory perception in patients with esophageal chest pain
13. Long-term follow up of symptomatic status of patients with noncardiac chest pain. Is diagnosis of esophageal etiology helpful?
14. Effects of omeprazole versus placebo in treatment of noncardiac chest pain and gastroesophageal reflux
15. High dose ranitidine for patients with non-cardiac chest pain and evidence of gastroesophageal reflux
16. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain
17. Combined gastric and oesophageal 24 hour monitoring in patients with reflux disease resistant to treatment with omeprazole
18. Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors
19. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: A controlled study in normal subjects
20. Imipramine in patient with chest pain despite normal coronary angiograms
21. One year psychological follow up of patients with chest pain and angiographically normal coronary arteries
22. Low dose trazodone for symptomatic patients with esophageal contraction abnormalities: A double-blind, placebo controlled trial
23. Long-term outcome from tricyclic antidepressant treatment of functional chest pain
24. Clinical and manometric effects of nitroglycerin in diffuse esophageal spasm
25. Diltiazem therapy for symptoms associated with nutcracker esophagus
26. Treatment of symptomatic nonachalasia esophageal motor disorders with botulinum toxin injection at the lower esophageal sphincter
27. Biofeedback and self-regulation in the treatment of diffuse esophageal spasm: A single-case study